Tirzepatide works on two biological pathways at once - GLP-1 and GIP. That dual mechanism is why it produces greater average weight loss than semaglutide alone, and why board-certified physicians prescribe it to patients who want the most clinically effective GLP-1 option available.
At HealthiCare, your tirzepatide prescription is reviewed by a licensed physician, filled by a US-based, FDA-registered pharmacy, and shipped to your door in 3 days. Fully itemized pricing, published before you start. The medication cost stays the same at every dose - from your first injection to your maintenance dose.
US-Based, FDA-Registered Pharmacy
Board-Certified Physicians, All 50 States
15,000+ GLP-1 Prescriptions Written
3-Day Delivery
Same Price Every Dose
No Membership Fee
Most telehealth providers charge more when your dose goes up. That structure creates a financial penalty for progress - the better the medication is working, the more expensive it becomes. HealthiCare is built the other way. Your price stays fixed from your starting dose through your highest maintenance dose, regardless of where your physician determines you need to be.
Tirzepatide is the active ingredient in Zepbound and Mounjaro. Most GLP-1 medications target a single receptor. Tirzepatide targets two - GLP-1 and GIP simultaneously - which is what separates it from semaglutide and earlier weight-loss medications. The dual-receptor mechanism suppresses appetite more aggressively, slows how quickly food leaves the stomach, and improves how the body handles insulin. That combination is why the clinical outcomes were stronger than anything seen before in a GLP-1 trial.
In the SURMOUNT-1 trial, patients on tirzepatide lost an average of 15 to 22.5% of their total body weight over 72 weeks, depending on dose. More than 90% of participants lost at least 5% of body weight. For context, semaglutide trials showed average losses closer to 15% at the highest doses - meaningful, but a different ceiling.
HealthiCare's tirzepatide is a personalized formulation prepared specifically for each patient by a US-based, FDA-registered pharmacy, based on a physician-reviewed intake. The active pharmaceutical ingredient is tirzepatide - the same molecule used in Zepbound. The difference is the source, the cost, and the clinical structure built around the prescription.
Brand-name Zepbound typically runs $1,100 to $1,400 per month without insurance. HealthiCare's personalized tirzepatide is available from $224.40 per month on the 3-month plan ($264.00/month billed monthly) - same active ingredient, physician oversight included, same medication cost at every dose level.
Medically reviewed by Dr. Jonah Mink, Beluga Health - board-certified, licensed across all 50 states.
HealthiCare is one of the only GLP-1 providers that publishes a complete, itemized cost structure publicly - no quiz required to see the price, no hidden fees that surface after you have committed.
Unlike our competitors, we show you exactly what you're paying for. NO membership fees ● NO surprises ● NO fine print.
Just honest, upfront pricing that shows every single cost.
Every line item is disclosed before you start. The medication cost stays the same at every dose level - 2.5mg through 15mg. When your physician moves your dose up, the medication line does not change. No hidden fees or surprises. Cancel anytime. Unlimited clinical and coach support is included in both plans.
If you are still deciding between tirzepatide and semaglutide - or weighing HealthiCare against a brand-name provider - here is a straightforward breakdown of the key differences:
Both semaglutide and tirzepatide are effective GLP-1 medications. The difference is the receptor mechanism - tirzepatide adds GIP activation, which produces meaningfully stronger appetite suppression and higher average weight loss in clinical trials. For patients who want the most effective option from the start, or who have not seen the results they expected on semaglutide, tirzepatide is the typical clinical step forward.
For a deeper look at how the two medications compare: Semaglutide vs. tirzepatide - what the clinical data actually shows.
Some patients receive their tirzepatide preparation with vitamin B12 (methylcobalamin) in the same injection. It is not a universal requirement - it is a clinical consideration that becomes relevant for a specific reason: when tirzepatide reduces appetite significantly, overall food intake drops. For patients whose diets were already low in B12, or who experience notable fatigue in the early weeks of treatment, adding methylcobalamin to the injection addresses that gap directly without requiring a separate supplement.
The B12 addition does not change the tirzepatide dose, the mechanism of action, or the titration schedule. It adds one component to the same injection you were already taking. Your prescribing physician reviews your intake history and advises whether it makes sense for your specific situation - at no change to the monthly cost.
Tirzepatide is started at a low dose and increased gradually - a protocol called titration. The reason is practical: starting slow significantly reduces the nausea and gastrointestinal side effects that cause many patients to stop GLP-1 treatment in the first month. Patients who go through proper titration almost always report better tolerability and more consistent results than those who try to escalate quickly.
The standard weekly injectable schedule:
Your HealthiCare physician manages this schedule. Not every patient reaches the highest dose - the goal is the lowest dose that produces the clinical response you need, not the highest dose possible. What does not change regardless of where your dose lands: the monthly cost stays at $224.40.
For the complete dosage guide with injection instructions: Tirzepatide dosage chart - starting doses, escalation schedule, and injection guidance.
Appetite reduction is usually the first change patients notice, often within the first week or two. The sensation is not hunger suppression in the way a stimulant works - it is closer to a reset of the signal that drives eating past the point of satiation. Most patients describe eating less not because they are forcing themselves to, but because the drive to keep eating simply quiets down.
Measurable weight loss typically becomes visible between weeks four and eight, with the rate of change accelerating through months three to six as the dose reaches a therapeutic level. Clinical trial data from SURMOUNT-1 and SURMOUNT-2:
Individual results vary based on starting weight, dose level, dietary habits, activity level, and other health factors. The numbers above are clinical trial averages, not guaranteed outcomes.
Side effects to understand before you start:
If any side effect requires a dosing adjustment or clinical conversation, that happens through your ongoing physician relationship - included in your monthly cost. There is no separate fee for clinical support.
For step-by-step injection guidance: Where to inject tirzepatide - site selection, technique, and rotation guide.
The clinical data on tirzepatide is compelling. But weight loss that lasts - the kind that does not reverse when you eventually taper off - requires more than a prescription. It requires the behavioral infrastructure to change how you eat, how you think about food, and how you stay accountable when the initial motivation fades. That is the part most telehealth providers do not offer.
HealthiCare is the clinical arm of the Healthi ecosystem: 1.8 million registered members, 24 coaches, and more than 20 live weekly meetings. The community was built on behavioral weight management long before GLP-1 prescriptions were part of the picture. It has helped members track over 1.66 million pounds lost. Your tirzepatide prescription brings you into that ecosystem as a core part of the product, not an optional add-on.
81,736+ five-star reviews reflect what that combination looks like in practice.
This page was reviewed by Dr. Jonah Mink and the Beluga Health physician network. Beluga Health provides board-certified physician coverage across all 50 US states. Every HealthiCare prescription is reviewed and approved by a licensed physician before it is dispensed.
Pharmacy partner: F&F Pharmacies Inc. - US-based, FDA-registered pharmacy, LegitScript-certified.
Start by completing the intake form - it takes about three minutes. A board-certified physician reviews your health history and, if you qualify, issues a tirzepatide prescription. Medication ships within 24 hours of approval. Most patients receive their first dose within three days of submitting their intake. Physician consultation, pharmacy preparation, and shipping are all included in the monthly cost.
Zepbound and Mounjaro are brand-name tirzepatide products manufactured by Eli Lilly and FDA-approved as finished drugs. HealthiCare's tirzepatide is a personalized formulation prepared by a US-based, FDA-registered pharmacy using the same active pharmaceutical ingredient. The active molecule - tirzepatide - is identical. What differs is the source, the cost, and the clinical structure: HealthiCare includes physician oversight and unlimited clinical and coach support. Brand-name Zepbound typically runs $1,100 to $1,400 per month out-of-pocket. HealthiCare's tirzepatide starts at $224.40 per month on the 3-month plan, or $264.00 per month billed monthly - with the medication cost staying the same at every dose level.
Yes. The active pharmaceutical ingredient is the same molecule - tirzepatide. What matters for clinical effectiveness is the active ingredient and the dose, both of which are identical. HealthiCare's pharmacy partner, F&F Pharmacies Inc., is a US-based, FDA-registered facility operating under USP standards. It is LegitScript-certified and domestically operated. Every prescription is physician-reviewed before preparation and dispensing.
HealthiCare offers two plans for tirzepatide. The monthly plan is $264.00 per month, billed monthly. The 3-month plan comes to $224.40 per month, billed as $673.20 every three months - a 15% saving. Both plans include medication, physician consultation, preparation, shipping, and unlimited clinical and coach support. The medication cost ($135) stays the same at every dose level - it does not increase when your dose escalates. No hidden fees. Cancel anytime.
Some patients receive their tirzepatide preparation with vitamin B12 (methylcobalamin) in the same injection. B12 supports energy metabolism and nerve function - relevant when reduced appetite lowers overall food intake and with it, dietary B12. Not every patient needs it. Your physician reviews your intake history and dietary patterns during the consultation and recommends it where there is a clinical reason to do so. It adds nothing to the monthly cost.
Most patients notice reduced appetite within the first one to two weeks - the mechanism starts working before the weight loss becomes visible on a scale. Measurable weight change typically begins between weeks four and eight. The rate accelerates through months three to six as the dose reaches a therapeutic range. In the SURMOUNT-1 trial, patients lost an average of 15 to 22.5% of body weight over 72 weeks depending on dose. Individual outcomes vary based on starting weight, dose level, diet, activity, and other health factors.
The standard starting dose is 2.5mg per week, injected subcutaneously. The dose typically increases every four weeks - to 5mg, then 7.5mg, and potentially upward to 10mg, 12.5mg, or 15mg - based on tolerance and physician assessment. Your HealthiCare physician manages the escalation schedule. The medication cost stays the same regardless of which dose level your physician determines is right for you. For the full guide: Tirzepatide dosage chart and escalation schedule.
Yes. HealthiCare operates through Beluga Health's physician network, licensed across all 50 US states. Intake, consultation, and prescription are handled entirely via telehealth. Medication ships from F&F Pharmacies to any US address with 3-day delivery from prescription approval.
Semaglutide targets the GLP-1 receptor only. Tirzepatide targets both GLP-1 and GIP simultaneously - that dual mechanism produces stronger appetite suppression and larger average weight loss in clinical trials. SURMOUNT-1 data showed average losses of 20 to 22.5% of body weight for tirzepatide at the highest doses, compared to roughly 15% for semaglutide at comparable doses. HealthiCare offers both: semaglutide from $147.90 per month and tirzepatide from $224.40 per month (3-month plan) or $264.00 per month (monthly plan), with the medication cost fixed at every dose level. For the clinical breakdown: Semaglutide vs. tirzepatide - a clinical comparison.
Side effect management and dose adjustments are handled through your ongoing clinical relationship with your HealthiCare physician - not billed separately. If nausea, gastrointestinal effects, fatigue, or anything else requires a dosing pause or change in your schedule, that conversation happens as part of your standard care. Unlimited clinical support is included in the $224.40 monthly cost. If your titration needs to move more slowly, your price stays the same.
15,000+ GLP-1 prescriptions written. 1.8 million people in the Healthi ecosystem. 81,736+ five-star reviews. Fully itemized pricing published before you start, with the medication cost fixed from your first dose to your maintenance dose.
Your intake takes three minutes. Physician review within 24 hours. Medication at your door in three days.
Want to compare your options first? See all GLP-1 treatments at HealthiCare or read our full breakdown of what GLP-1 treatment actually costs.
